甘精胰岛素、地特胰岛素、人胰岛素对3T3-L1脂肪细胞PPARγ2mRNA表达的影响(3)
 |
| 第1页 |
参见附件。
[9] Haak T,Tiengo A,Draeger E,et al.Lower withinsubject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes[J].Diabetes Obes Metab，2005,7(1):5664.
[10] Hollander P,Cooper J,Bregnhoj J.A 52week,multinational,openlabel,parallelgroup,noninferiority,treattotarget trial comparing insulin detemir with insulin glargine in a basalbolus regimen with mealtime insulin aspart in patients with type 2 diabetes[J].Clin Ther,2008,30(11):19761987.
[11] Wada T,Azegami M,Sugiyama M,et al.Characteristics of signalling properties mediated by longacting insulin analogue glargine and detemir in target cells of insulin[J].Diabetes Res Clin Pract，2008,81:269277.
[12] Kurtzhals P,Schaffer L,Sorensen A,et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use[J].Diabetes，2000,49:9991005.
作者简介：姬海涛(1982—)，男，现为山西医科大学第一医院内分泌科在读硕士研究生(邮编：030001)；杨静(通讯作者)，工作于山西医科大学第一医院(邮编：030001)。
(收稿日期：20120302)
(本文编辑郭怀印)
您现在查看是摘要介绍页，详见PDF附件(1985kb)。